FEDERATED HERMES, INC. - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 168 filers reported holding CLOVIS ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2021$90,000
+1185.7%
20,194
+1631.9%
0.00%
Q2 2021$7,000
-12.5%
1,166
-0.1%
0.00%
Q1 2021$8,000
+166.7%
1,167
+122.7%
0.00%
Q4 2020$3,000
-40.0%
524
-34.0%
0.00%
Q3 2020$5,000
-16.7%
794
-2.6%
0.00%
Q2 2020$6,0000.0%815
-5.8%
0.00%
Q1 2020$6,000
-99.7%
865
-99.6%
0.00%
-100.0%
Q4 2019$2,060,000
+119.1%
197,572
-17.4%
0.01%
+150.0%
Q3 2019$940,000
+285.2%
239,095
+2780.7%
0.00%
+100.0%
Q3 2018$244,000
-35.3%
8,3000.0%0.00%0.0%
Q2 2018$377,000
-13.9%
8,3000.0%0.00%0.0%
Q1 2018$438,000
-59.7%
8,300
-48.1%
0.00%
-66.7%
Q4 2017$1,088,000
+32.0%
16,000
+60.0%
0.00%
+50.0%
Q3 2017$824,000
-70.0%
10,000
-65.9%
0.00%
-75.0%
Q2 2017$2,746,000
+86.9%
29,330
+27.2%
0.01%
+100.0%
Q1 2017$1,469,000
+129.2%
23,065
+59.9%
0.00%
+100.0%
Q4 2016$641,000
+290.9%
14,423
+20.6%
0.00%
Q2 2016$164,000
-91.1%
11,957
-40.2%
0.00%
-100.0%
Q3 2015$1,839,000
+4.6%
20,0000.0%0.01%
+20.0%
Q2 2015$1,758,000
+58.0%
20,000
+33.3%
0.01%
+66.7%
Q1 2015$1,113,000
+98.8%
15,000
+50.0%
0.00%
+50.0%
Q4 2014$560,000
-17.6%
10,000
-33.3%
0.00%0.0%
Q3 2014$680,000
-45.2%
15,000
-50.0%
0.00%
-50.0%
Q2 2014$1,242,000
-10.3%
30,000
+50.0%
0.00%
-20.0%
Q1 2014$1,385,000
+13.9%
20,0000.0%0.01%0.0%
Q3 2013$1,216,000
+81.5%
20,000
+100.0%
0.01%
+66.7%
Q2 2013$670,00010,0000.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders